Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies

Robert H. Mach, Robert T. Luedtke

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Abstract

The dopamine D2-like receptors (ie, D2/3 receptors) have been the most extensively studied CNS receptor with Positron Emission Tomography (PET). The 3 different radiotracers that have been used in these studies are [11C]raclopride, [18F]fallypride, and [11C]PHNO. Because these radiotracers have a high affinity for both dopamine D2 and D3 receptors, the density of dopamine receptors in the CNS is reported as the D2/3 binding potential, which reflects a measure of the density of both receptor subtypes. Although the development of D2- and D3-selective PET radiotracers has been an active area of research for many years, this by and large presents an unmet need in the area of translational PET imaging studies. This article discusses some of the challenges that have inhibited progress in this area of research and the current status of the development of subtype selective radiotracers for imaging D3 and D2 dopamine receptors with PET.

Original languageEnglish
Pages (from-to)291-298
Number of pages8
JournalJournal of Labelled Compounds and Radiopharmaceuticals
Volume61
Issue number3
DOIs
StatePublished - 1 Mar 2018

Fingerprint

Positron emission tomography
Positron-Emission Tomography
Dopamine D2 Receptors
Dopamine
Dopamine D3 Receptors
Imaging techniques
Raclopride
Dopamine Receptors
Research

Keywords

  • D2 receptors
  • D3 receptors
  • PET radioligands

Cite this

@article{bd99c78499234b5cb52d71bab5d8f7fe,
title = "Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies",
abstract = "The dopamine D2-like receptors (ie, D2/3 receptors) have been the most extensively studied CNS receptor with Positron Emission Tomography (PET). The 3 different radiotracers that have been used in these studies are [11C]raclopride, [18F]fallypride, and [11C]PHNO. Because these radiotracers have a high affinity for both dopamine D2 and D3 receptors, the density of dopamine receptors in the CNS is reported as the D2/3 binding potential, which reflects a measure of the density of both receptor subtypes. Although the development of D2- and D3-selective PET radiotracers has been an active area of research for many years, this by and large presents an unmet need in the area of translational PET imaging studies. This article discusses some of the challenges that have inhibited progress in this area of research and the current status of the development of subtype selective radiotracers for imaging D3 and D2 dopamine receptors with PET.",
keywords = "D2 receptors, D3 receptors, PET radioligands",
author = "Mach, {Robert H.} and Luedtke, {Robert T.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1002/jlcr.3558",
language = "English",
volume = "61",
pages = "291--298",
journal = "Journal of Labelled Compounds and Radiopharmaceuticals",
issn = "0362-4803",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies. / Mach, Robert H.; Luedtke, Robert T.

In: Journal of Labelled Compounds and Radiopharmaceuticals, Vol. 61, No. 3, 01.03.2018, p. 291-298.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies

AU - Mach, Robert H.

AU - Luedtke, Robert T.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The dopamine D2-like receptors (ie, D2/3 receptors) have been the most extensively studied CNS receptor with Positron Emission Tomography (PET). The 3 different radiotracers that have been used in these studies are [11C]raclopride, [18F]fallypride, and [11C]PHNO. Because these radiotracers have a high affinity for both dopamine D2 and D3 receptors, the density of dopamine receptors in the CNS is reported as the D2/3 binding potential, which reflects a measure of the density of both receptor subtypes. Although the development of D2- and D3-selective PET radiotracers has been an active area of research for many years, this by and large presents an unmet need in the area of translational PET imaging studies. This article discusses some of the challenges that have inhibited progress in this area of research and the current status of the development of subtype selective radiotracers for imaging D3 and D2 dopamine receptors with PET.

AB - The dopamine D2-like receptors (ie, D2/3 receptors) have been the most extensively studied CNS receptor with Positron Emission Tomography (PET). The 3 different radiotracers that have been used in these studies are [11C]raclopride, [18F]fallypride, and [11C]PHNO. Because these radiotracers have a high affinity for both dopamine D2 and D3 receptors, the density of dopamine receptors in the CNS is reported as the D2/3 binding potential, which reflects a measure of the density of both receptor subtypes. Although the development of D2- and D3-selective PET radiotracers has been an active area of research for many years, this by and large presents an unmet need in the area of translational PET imaging studies. This article discusses some of the challenges that have inhibited progress in this area of research and the current status of the development of subtype selective radiotracers for imaging D3 and D2 dopamine receptors with PET.

KW - D2 receptors

KW - D3 receptors

KW - PET radioligands

UR - http://www.scopus.com/inward/record.url?scp=85044517181&partnerID=8YFLogxK

U2 - 10.1002/jlcr.3558

DO - 10.1002/jlcr.3558

M3 - Article

VL - 61

SP - 291

EP - 298

JO - Journal of Labelled Compounds and Radiopharmaceuticals

JF - Journal of Labelled Compounds and Radiopharmaceuticals

SN - 0362-4803

IS - 3

ER -